Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

synoptis pharma sp. z o.o. - doxycyclini hyclas - kapsułki twarde - 100 mg

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aliud pharma gmbh (3270510) - doxycyclin-monohydrat - hartkapsel - teil 1 - hartkapsel; doxycyclin-monohydrat (19716) 104,1 milligramm

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

pierre fabre medicament - doxycycline monohydratée 100 - comprimé - 100,00 mg - pour un comprimé > doxycycline monohydratée 100,00 mg - antibacteriens a usage systemique - classe pharmacothérapeutique antibacteriens a usage systemique - code atc : j01aa02la doxycycline est un antibiotique antibactérien de la famille des tétracyclines.il est indiqué dans le traitement des infections à germes sensibles à la doxycycline dans leurs manifestations respiratoires, génitales, urinaires, oculaires, dentaires ou générales.votre médecin peut aussi vous le prescrire dans le traitement de certaines formes d’acné ainsi que dans la rosacée dans ses manifestations cutanées ou oculaires.il est indiqué pour la prévention du paludisme dans certaines zones d’endémie en cas de résistance, de contre-indication ou d’intolérance à un autre antipaludique habituellement utilisé dans cette indication telle que la méfloquine.

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

tarchomińskie zakłady farmaceutyczne "polfa" s.a. - doxycyclinum - tabletki do sporządzania zawiesiny doustnej - 100 mg

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

polfarmex s.a. - doxycyclinum - kapsułki twarde - 100 mg

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop sa-nv - phénobarbital sodique 100 mg/ml - solution injectable - 100 mg/1 ml - phénobarbital sodique 100 mg/ml - phenobarbital

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - other conditions: protect from moisture. indications: infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram- negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjuction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus infuenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aliud pharma gmbh (3270510) - doxycyclinhyclat - tablette - teil 1 - tablette; doxycyclinhyclat (03877) 230,8 milligramm

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

dopharma research b.v. - doxycyclinehyclaat - poeder voor gebruik in drinkwater - doxycyclinehyclaat 1000 mg/g, - doxycycline - kalveren; varkens

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop sa-nv - fenobarbital 100 mg - tablet - 100 mg - fenobarbital 100 mg - phenobarbital